12-Drug Urine Test Drugdiag® 12T - New Synthetic Drugs

Broad-spectrum NPS urine testDrugdiag® 12T NPS: broad-spectrum urine test The Drugdiag® 12T NPS is a urine test intended for contexts where broad screening is necessary, especially when new synthetic drugs, synthetic cannabinoids, cathinones, or mixtures of uncertain composition are suspected. This product must be presented with increased rigor: the exact panel, positivity thresholds, cross-reactions, and analytical limits must be verified with the manufacturer’s leaflet of the batch used. No rapid test should be presented as capable of detecting all existing substances. Broad-spectrum NPS screening An expanded panel for complex situations The 12T NPS format is suitable when the situation goes beyond simple THC, cocaine, or opiate screening. It can be useful when a synthetic product, fake CBD, PTC, cathinone, or emerging molecule is suspected. Safety rule: the leaflet of the delivered batch remains the reference source. It must be kept with the test to verify the exact panels and thresholds. Recommended uses Enhanced preventionBroad approach when several substance families need to be considered. Specialized structuresCSAPA, health, prevention, professional environment, or supervised field actions. Chemical submission and alertsPossible screening tool, never replacing medical care or specialized analysis. Limits and confirmation Screening result A broad-spectrum rapid test remains a preliminary result. In cases of medical, official, professional, judicial, or disputed issues, specialized analytical confirmation may be necessary. Important: a negative result does not exclude all synthetic substances not covered by the panel. The chemistry of NPS is constantly evolving. Product sheet written and updated by the AMA Prévention team. Information should be interpreted according to the manufacturer’s instructions, the context of use, and applicable regulations.